title: Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner's syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus.
authors.affiliation: Department of Orthopaedic Surgery, Nara Medical University, Kashihara, Nara, Japan. Electronic address: shinji104@mail.goo.ne.jp.
authors.forename: Shinji
authors.initials: S
authors.lastname: Tsukamoto
authors.affiliation: Department of Gastroenterology, Endocrinology and Metabolism, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Yukako
authors.initials: Y
authors.lastname: Kurematsu
authors.affiliation: Department of Orthopaedic Surgery, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Kanya
authors.initials: K
authors.lastname: Honoki
authors.affiliation: Department of Orthopaedic Surgery, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Kido
authors.affiliation: Department of Cardiorenal and Metabolic Medicine, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Somekawa
authors.affiliation: Department of Gastroenterology, Endocrinology and Metabolism, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Kaya
authors.affiliation: Department of Gastroenterology, Endocrinology and Metabolism, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Tomomi
authors.initials: T
authors.lastname: Sadamitsu
authors.affiliation: Department of Gastroenterology, Endocrinology and Metabolism, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fukui
authors.affiliation: Department of Orthopaedic Surgery, Nara Medical University, Kashihara, Nara, Japan.
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Tanaka
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D001927:Brain Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D020790:Diabetes Insipidus, Neurogenic / Q000139:chemically induced* / Q000000981:diagnostic imaging; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000000981:diagnostic imaging; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018570:Risk Assessment; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed / Q000379:methods; D014898:Werner Syndrome / Q000175:diagnosis / Q000628:therapy
chemical_list: D004317:Doxorubicin; D007069:Ifosfamide